It may be the simple telephone that helps save lives. Anita Kinney, PhD, RN have found that personalized cancer screening messages over the phone can better help promote preventive cancer measures.
Santa Fe is renowned for its culture and art; this March it will host an art show based on science. The fifth annual “Art of Systems Biology and Nanoscience,” is a two-day public event celebrating new and fascinating ideas and images from the emerging fields of systems biology and nanoscience. The images on display demonstrate the beauty of life at a molecular level.
New Mexico legislators will play in the annual “Hoops 4 Hope” basketball game to raise awareness and money for cancer treatment and research. The proceeds will benefit the University of New Mexico Cancer Center.
Teresa Stewart is the Director of the Clinical Research Office at the University of New Mexico Cancer Center and the Executive Director of the New Mexico Cancer Care Alliance. She has just been named to the American Society of Clinical Oncology’s 10-member Cancer Research Forum Committee.
A cross-institutional, international team of scientists recently discovered a new, important step of the process that grows new blood vessels, a discovery that could lead to a new way to combat cancer.
Melanie Royce, MD, PhD, was recently named to the American Cancer Society Great West Division Board of Directors. Dr. Royce is a Professor of Medicine at the University of New Mexico School of Medicine and is Director of the Breast Multidisciplinary Clinic and Program at the UNM Cancer Center.
The strong partnership between Sandia National Laboratories and the University of New Mexico Health Sciences Center has won the Federal Laboratory Consortium's “Outstanding Regional Partnership Award” for outstanding efforts to promote technology transfer between federal government facilities and the private or public sectors. The award will be presented at the October 21-23 Regional Meeting in San Diego.
The University of New Mexico Cancer Center Radiation Oncology Department recently received the widely recognized accreditation from the American College of Radiology.
The annual breast cancer awareness Football game honors New Mexico's breast cancer survivors. The game is sponsored by UNM Athletics, UNM Hospitals and UNM Cancer Center.
Charles Bellows, MD, FACS, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine. He will bring a focus on balancing academic pursuits and research with patient care.
Jeremy Edwards, PhD, is a University of New Mexico Professor in the Department of Molecular Genetics and Microbiology and in the Department of Chemical Engineering. He is a full member of the UNM Cancer Center. Dr. Edwards recently won a 3-year, $1.35 million grant from the National Institutes of Health to develop technology to complete the human genome and to step closer to personalizing medicine.
UNM welcomes Christopher Demas, MD. Dr. Demas is a newly hired University of New Mexico Professor of Plastic and Reconstructive Surgery. He is also the new Chief of the Division of Plastic and Reconstructive Surgery in the Department of Surgery at the UNM School of Medicine. He practices at UNM Hospital and UNM Cancer Center. One of his specialties is breast reconstruction after cancer treatment.
Dr. Vittorio Cristini, at the UNM Cancer Center, and his colleagues have just published a paper describing their mathematical model of cancer. The model uses physics and the patient's own tumor information to accurately predict treatment outcomes.
In a study recently published online in The Journal of the American Medical Association Dermatology, Marianne Berwick, PhD, and her international team of melanoma researchers confirmed that the chances of dying from skin cancer depend strongly upon how thick the primary tumor is. But — unexpectedly — the team also found that those having more than one primary tumor have better survival odds.
Scott Ness, PhD, is convening an international conference at the University of New Mexico Cancer Center to study the MYB protein. MYB is implicated in many cancers. The MYB Conference will foster new research efforts to study mutations of this protein and their impact on various cancers.
The Cancer Program at Memorial Medical Center in Las Cruces reached 100 enrollments in clinical trials last month. To celebrate, Memorial Medical Center will host a HERO event for all southern New Mexico clinical trial participants and their guests on June 15th.
Specialized cells, called “hematopoietic stem cells,” produce the new blood cells. Scientists thought hematopoietic stem cells stayed in the bone marrow but recent research has revealed that they, too, travel to the problem site: to the heart if a heart attack is in progress, or to the brain in the case of a stroke. Why these cells leave the bone marrow, how they know where to go, and what they do when they reach their target is what Jennifer Gillette, PhD, will use her $300,000 American Heart Association grant to study over the next four years.
The Mexican Ministry of Foreign Affairs recently awarded the UNM Cancer Center a $36,000 grant to continue its health initiatives statewide through the Ventanilla de Salud (“Health Window”) program.
Four world-renowned cancer physicians and scientists joined the University of New Mexico Health Sciences Center and the UNM Cancer Center. They are Wadih Arap, MD, PhD, and Renata Pasqualini, PhD, experts in discovery of new cancer drugs and treatment of prostate and other advanced cancers; Martin J. Edelman, MD, FACP, expert in treatment of lung and aerodigestive cancers; and Anita Kinney, PhD, expert in cancer prevention and public health, community-based research, and cancer health disparities.